Member Info for Bobbler

I made a small buy today , showing as a sell. Nothing changes

Silverfoil- tell them to look for an A Hole in a pantomime outfit.

Please don’t forget Leaving without saying goodbye can mean that we feel unresolved and unable to have a sense of closure. We may experience all kind of feelings in relation to this; perhaps we might be left guilty, regretful, grief-stricken, sad, angry or remorseful. There will most likely be a sense of things being unfinished.

Upward love spiral imminent

@ Bailiff, I look forward to your next one. Have a fun day 😀

Leggster- very well called 👍

Bailiff, your quick off the ball this morning 😀

puma, you talk some ****e 😂😂

Https://www.dailymail.co.uk/health/article-12479821/New-vaccines-tailor-fight-patients-tumour-revolutionise-cancer-care-speak-one-UK-patients-benefit.html

Should have said £6 by Christmas

Worked out fine for Kodal

The funding proposal is for a 24-month secured convertible loan note (CLN) with no repayments before 18 months, and a 10% per year interest, rolled up and payable on maturity, and an implementation fee of 5% of each tranche advanced.

Riverfort has the right, but not the obligation, to convert all or part of any outstanding balance of the CLN, up to a maximum of US$1.25mln for a 20% stake in Kodal's gold assets.

Interesting..........MAJWAND

March 2021 Kodal Minerals is close to reaching an agreement with Riverfort Global Capital Ltd to receive up to US$2.5mln in funding.

Following negotiations between Kodal and Riverfort, the terms of a previously announced funding proposal have been revised and it is anticipated that the final binding agreement will be ready for execution shortly, Kodal said.

Share price stats:

March 21 Price : 0.12p

Past year up 98%

Todays Price: 0.63p

Guessing the Puma and its pet have twitching sphincters this morning :-)

with this level of ****wombling i predict some serious news is inbound. why else would they bother??????

£4 by christmas

Basser- remember this:

“ On the 5th December 2016 Physiomics announced an initial payment by Sareum for modelling carried out by the Company in 2010 to support the identification of an optimal combination regime of a Chk1 inhibitor and a DNA-targeting chemotherapy using the pre-clinical version of the Company’s Virtual Tumour technology. The payment was triggered by a number of pre-conditions including the announcement on 27th September 2016 by Sareum that its partner, the CRT Pioneer Fund, had licensed exclusive and worldwide rights for a Chk1 inhibitor cancer drug candidate CCT245737 (to be renamed PNT737) to ProNAi Therapeutics, Inc. (NASDAQ: DNAI)”.

Could be a little bit of history repeating itself 😀

MJ wanco, it’s boring and no one’s interested.

I see your Prem punt is doing well 😂

Bailiff - I would think there’s a very high chance he isn’t the father.

One rule- it’s called a two headed pea-nus

Things it’s time we hired a big game hunter to rid the board of this pea-nos.

I know it’s difficult but I agree with the suggestion that we all disengage with this womble.

We will soon be saying “wouldn’t want to be in this at the weekend” 😀😀